PRESS RELEASE published on 10/01/2026 at 22:15, 21 days 5 hours ago NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier Nanobiotix nomme Arnd Christ en tant que directeur financier et membre du directoire, apportant plus de 20 ans d'expérience dans les sociétés de biotechnologie, succédant à Bart Van Rhijn Biotechnologie Développement Clinique Directeur Financier NANOBIOTIX Arnd Christ
PRESS RELEASE published on 10/01/2026 at 22:15, 21 days 5 hours ago NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer Nanobiotix appoints Arnd Christ as CFO, bringing extensive financial leadership experience to advance treatment platforms for patients with cancer and major diseases CFO Cancer Treatment Financial Leadership NANOBIOTIX Arnd Christ
BRIEF published on 09/24/2026 at 22:20, 28 days 5 hours ago NANOBIOTIX annonce ses progrès opérationnels et financiers pour le premier semestre 2026 Traitement Du Cancer Mise À Jour Financière Étude De Phase 1 NANOBIOTIX JNJ-1900 (NBTXR3)
BRIEF published on 09/24/2026 at 22:20, 28 days 5 hours ago NANOBIOTIX Reports First Half 2026 Operational and Financial Progress Cancer Treatment Financial Update NANOBIOTIX Phase 1 Study JNJ-1900 (NBTXR3)
PRESS RELEASE published on 09/24/2026 at 22:15, 28 days 5 hours ago NANOBIOTIX Provides First Half 2026 Operational and Financial Update Nanobiotix provides operational and financial update for first half of 2026, showcasing progress in clinical development and successful global offering, reinforcing position in cancer treatment innovation Cancer Treatment Clinical Development Operational Update Financial Update NANOBIOTIX
PRESS RELEASE published on 09/24/2026 at 22:15, 28 days 5 hours ago NANOBIOTIX fait le point sur ses activités et ses résultats financiers du premier semestre 2026 Nanobiotix annonce des progrès cliniques et financiers prometteurs pour le premier semestre 2026, notamment grâce à des résultats positifs et une trésorerie renforcée Résultats Financiers Trésorerie NANOBIOTIX JNJ-1900 Progrès Cliniques
BRIEF published on 09/22/2026 at 22:20, 1 month ago Informations Mensuelles sur les Droits de Vote de Nanobiotix Euronext Paris Droits De Vote Capital Social Nasdaq NANOBIOTIX
BRIEF published on 09/22/2026 at 22:20, 1 month ago Voting Rights and Shares Capital Update of Nanobiotix Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 09/22/2026 at 22:20, 1 month ago Mise à jour des droits de vote et du capital social de Nanobiotix Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
BRIEF published on 09/22/2026 at 22:20, 1 month ago Monthly Information on Nanobiotix Voting Rights Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
Published on 10/23/2026 at 02:20, 1 hour 27 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 4 hours 17 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 5 hours 17 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 11 hours 47 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 13 hours 17 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 01:55, 1 hour 51 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 5 hours 36 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 7 hours 46 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 8 hours 1 minute ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 9 hours 1 minute ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 9 hours 47 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
